Clinical Trial Update: Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant clopidogrel for Staphylococcus aureus bacteremia; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Bacteremia Due to Staphylococcus Aureus | Phase 2 | Status: NOT_YET_RECRUITING